Disseminated Cryptococcosis in a Non-Hodgkin's Lymphoma Patient with Late-Onset Neutropenia Following Rituximab-CHOP Chemotherapy: A Case Report and Literature Review

Mycopathologia

Volumn 172, Issue 3, 2011, Pages 227-232

  Hirai, Yuji ^a   Ainoda, Yusuke ^a   Shoji, Takayo ^a   Fujita, Takahiro ^a   Yoshinaga, Kentaro ^a   Shiseki, Masayuki ^a   Mori, Naoki ^a   Teramura, Masanao ^a   Totsuka, Kyoichi ^a   Motoji, Toshiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cryptococcosis; Late onset; Malignant lymphoma; Neutropenia; Rituximab

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUCONAZOLE; FLUCYTOSINE; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HUMAN; ISOLATION AND PURIFICATION; NEUTROPENIA; NONHODGKIN LYMPHOMA; TREATMENT OUTCOME;

AGED; AMPHOTERICIN B; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUCONAZOLE; FLUCYTOSINE; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOMA, NON-HODGKIN; NEUTROPENIA; PREDNISOLONE; TREATMENT OUTCOME; VINCRISTINE;

FILOBASIDIELLA NEOFORMANS;

EID: 79960587913     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9423-9     Document Type: Article

References (36)

1. Kimby E. Tolerability and safety of rituximab (MabThera). Cancer Treat Rev. 2005; 31: 456-73.
2. Voog E, Morschhauser F, Solal-Céligny P. Neutropenia in patients treated with Rituximab. N Eng J Med. 2003; 348(26): 2691-4.
3. Tesfa D, Gelius T, Sander B, Kimby E, Fadeel B, Palmblad J. Hägglund H. Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis. Med Oncol. 2008; 25: 374-9.
4. Chaiwatanatorn K, Lee N, Grigg A, Filshie R, Firkin F. Delayed-onset neutropenia associated with rituximab therapy. Br J Hematol. 2003; 121: 913-8.
5. Nitta E, Izutsu K, Sato T, Ota Y, Takeuchi K, Kamijo A, Takahashi K, Oshima K, Kanda Y, Chiba S, Motokura T, Kurokawa M. A high incidence of late-onset neutropenia following rituzimab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study. Ann Oncol. 2007; 18(2): 364-9.
6. Lemieux B, Tartas S, Traulle C, Espinouse D, Thieblemont C, Bouafia F, Alhusein Q, Antal D, Salles G, Coiffier B. Non-Hodgkin's lymphoma Rituximab-related late-onset neutropenia autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma. Bone Marrow Transplant. 2004; 33: 921-3.
7. Hirayama Y, Kohda K, Konuma Y, Hirata Y, Kuroda H, Fujimi Y, Shirao S, Kobune M, Takimoto R, Matsunaga T, Kato J. Late onset neutropenia and immunoglobulin suppression of the patients with malignant lymphoma following autologous stem cell transplantaion with rituximab. Intern Med. 2009; 48: 57-60.
8. Lai GG, Lim ST, Tao M, Chan A, Li H, Quek R. Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma. Am J Hematol. 2009; 84(7): 414-7.
9. Fukuno K, Tsurumi H, Ando N, Kanemura N, Goto H, Tanabashi S, Okamoto K, Moriwaki H. Late-onset neutropenia in patients treated with rituximab for non-Hodgkin's lymphoma. Int J Hematol. 2006; 84: 242-7.
10. Aksoy S, Harputluoglu H, Kilickap S, Dede DS, Dizdar O, Altundag K, Barista I. Rituximab-related viral infections in lymphoma patients. Leuk Lymphom. 2007; 48(7): 1307-12.
11. Ram R, Ben-Bassat I, Shpilberg O, Polliack A, Raanani P. The late adverse events of rituximab therapy-rare but there!. Leuk Lymphom. 2009; 50(7): 1083-95.
12. Cornely OA, Heidecke CN, Karthaus M. Opportunistic infections (OI) following monoclonal antibody treatment. J Clin Oncol. 2005; 23(16S): 2562. (From the 2005 ASCO Annual Meeting).
13. Vidal L, Gafter-Gvili A, Leibovici L, Dreyling M, Ghielmini M, Hsu Schmitz SF, Cohen A, Shpilberg O. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst. 2009; 101(4): 248-55.
14. Aksoy S, Dizdar O, Hayran M, Harputluoǧlu H. Infections complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta analysis. Leuk Lymphom. 2009; 50(3): 357-65.
15. Rafailidis PI, Kakisi OK, Vardakas K, Falagas ME. Infectious complications of monoclonal antibodies used in cancer therapy. Cancer. 2007; 109(11): 2182-9.
16. Lin PC, Hsiao LT, Poh SB, Wang WS, Yen CC, Chao TC, Liu JH, Chiou TJ, Chen PM. Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP. Ann Hematol. 2007; 86: 95-100.
17. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious disease society of America. Clin Infect Dis. 2010; 50(3): 291-322.
18. Muñoz P, Giannella M, Valerio M, Soria T, Díaz F, Longo JL, Bouza E. Cryptococcal meningitis in a patient treated with infliximab. Diagn Microbiol Infect Dis. 2007; 57: 433-46.
19. Korfel A, Menssen HD, Schwartz S, Thiel E. Cryptococcus in Hodgkin's disease: description of two cases and review of the literature. Ann Hematol. 1998; 76: 283-6.
20. Escudier E, Cordonnier C, Poirier J. Infections of the central nervous system in malignant hemopathies. Rev Neurol. 1986; 142(2): 116-25. (French).
21. Dinçol G, Kahraman R. Cryptococcus neoformans meningitis in a patient with hairy cell Leukmia. Am J Hematol. 2006; 81: 387.
22. Reisfeld-Zadok S, Elis A, Szyper-Kravitz M, Chowers M, Lishner M. Cryptococcal meningitis in chronic lymphocytic leukemia patients. Isr Med Assoc J. 2009; 11: 437-9.
23. Rhew DC, Gaultier CR, Daar ES, Zakowski PC, Said J. Infections in patients with chronic adult T-cell leukemia/lymphoma: case report and review. Clin Infect Dis. 1995; 21: 1014-6.
24. Sánchez-Ojanguren J, Isern-Segura I, Chico-Chumillas C, Javaloyas-de-Morlius M. Cryptococcus neoformans meningoencephalitis in a patient treated with rituximab. Med Clin. 2009; 133(4): 157-8. (Spanish).
25. Vigouroux S, Morin O, Milpied N, Mahé B, Rapp MJ, Harousseau JL. Cryptococcus neoformans infection in hematologic malignancies. Rev Med Interne. 2000; 21: 955-60. (French).
26. Finke R, Strobel ES, Kroepelin T, Guzman J, Klein PJ, Schaefer HE, Kappe R, Müller J. Disseminated cryptococcosis in a patient with malignant lymphoma. Mycoses. 1988; 31(1): 102-8.
27. Eric Searls D, Sico JJ, Bulent Omay S, Bannykh S, Kuohung V, Baehring J. Unusual presentations of nervous system infection by Cryptococcus neoformans. Clin Neuro Nurosurg. 2009; 111: 638-42.
28. Romano C, Taddeucci P, Donati D, Miracco C, Massai L. Primary cutaneous cryptococcosis due to Cryptococcus neoformans in a woman with non-Hodgkin's lymphoma. Acta Derm Venereol. 2001; 81(3): 220-1.
29. Sánchez A, Cantos B, España P, Salas C, Provencio M. Hodgkin's disease and intercurrent processes that may simulate a relapse. Clin Transl Oncol. 2008; 10(7): 439-41.
30. Fujita Y, Kasahara K, Uno K, Konishi M, Maeda K, Yoshimoto E, Murakawa K, Mikasa K, Amano I, Morii T, Kimura H. Amphotericin B-induced nephrogenic diabetes insipidus in a case of cryptococcemia. Intern Med. 2005; 44(5): 458-61.
31. Bolignano G, Chindemi G, Criseo G. Cryptococcal meningoencephalitis in a patient with Hodgkin's lymphoma: successful treatment with fluconazole. Mycoses. 1991; 34(1-2): 63-5.
32. Amthor M, Arents B, Bartelheimer E. Cryptococcal sepsis simulating miliary tuberculosis in malignant lymphoma. Pneumologie 1991; 45(3): 110-3. (German).
33. Sharma M, Khatib R, Jones BA, Fakih MG. Cryptococcus neoformans myositis without dissemination. Scand J Infect Dis. 2002; 34(11): 858-9.
34. Okawa Y, Shimada T, Nagasaki E, Nozato A, Mizoroki F, Kobayashi M. Pulmonary cryptococcosis occurring 6 months after cladribine therapy for relapsed follicular lymphoma. Rinsho Ketsueki. 2006; 47(7): 650-5. (Japanese).
35. Nowicka J, Mazur G, Kuliczkowski K, Gola A, Kochman A, Baran E, Walów B. Cryptococcal infection and lymphogranulomatous infiltration of the central nervous system in Hodgkin's disease. Mycoses. 1994; 37: 439-41.
36. Rajkumar K, Rajkumar T, Sagar TG, Maitreyan V, Shanta V. Cryptococcal Meningitis in a patient with Hodgkin's Lymphoma. J Assoc Physicians India. 1992; 40(10): 707-8.